# The GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant mice by modulating macrophage phenotype

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-glp-1-analogue-lixisenatide-decreases-atherosclerosis-in-insulin-resistant/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ángela Vinué,Jorge Navarro,Andrea Herrero-Cervera,Marta García-Cubas,Irene Andrés‐Blasco,Sergio Martínez‐Hervás,José T. Real,Juan F. Ascaso,Herminia González‐Navarro |
| Citations | 133 |
| DOI | 10.1007/s00125-017-4330-3 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://link.springer.com/content/pdf/10.1007/s00125-017-4330-3.pdf |
| OpenAlex ID | https://openalex.org/W2626992208 |
| PMID | 28608285 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Sergio Martínez‐Hervás](https://scholariq.org/researchers/sergio-martinez-hervas/)

## Paper journal

- [Diabetologia](https://scholariq.org/journals/diabetologia/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Adipokines, Inflammation, and Metabolic Diseases](https://scholariq.org/topics/adipokines-inflammation-and-metabolic-diseases/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.